person · Reporting owner
HARRISON WILLIAM B JR
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | Director | April 13, 2016 | April 13, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date April 13, 2016 · Filed April 13, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,400 |
Reported balance
After 2016-04-13 transaction · row 1
1 source rowRow 1 · 2016-04-13 · Exercise / conversion · Acquired 5,000 · Balance 16,400 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.44 · Expires 2016-04-27 | Direct | 0 |
Reported balance
After 2016-04-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-04-13 · Exercise / conversion · Disposed 5,000 · Balance 0 F1: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009. |
Filing footnotes · ownership attribution and instrument terms
F1: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cadence Bancorporation
Report date October 29, 2021 · Filed October 29, 2021
Section 16 reporting ended · disclosed 2021-10-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-10-29 transaction · row 1
1 source rowRow 1 · 2021-10-29 · Disposition to issuer · Disposed 120,102 · Balance 0 F1: Disposed of in connection with the Agreement and Plan of Merger by and between BancorpSouth Bank ("BXS") and Cadence Bancorporation ("Cadence"), dated April 12, 2021 and amended as of May of 27, 2021 (the "Merger Agreement"), pursuant to which Cadence was merged with and into BXS, effective October 29, 2021 (the "Merger"). Pursuant to the Merger, each issued and outstanding share of Cadence common stock par value $0.01 was converted into the right to receive .70 shares of the BXS's common stock par value $2.50 per share ("the Exchange Ratio"), subject to cash in lieu of fractional shares. The opening price of the BXS's common stock on the New York Stock Exchange on the effective date of the Merger was $29.16. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Cadence common stock. |
| Class A Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2021-10-29 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-10-29 · Disposition to issuer · Disposed 571,961 · Balance 0 F1: Disposed of in connection with the Agreement and Plan of Merger by and between BancorpSouth Bank ("BXS") and Cadence Bancorporation ("Cadence"), dated April 12, 2021 and amended as of May of 27, 2021 (the "Merger Agreement"), pursuant to which Cadence was merged with and into BXS, effective October 29, 2021 (the "Merger"). Pursuant to the Merger, each issued and outstanding share of Cadence common stock par value $0.01 was converted into the right to receive .70 shares of the BXS's common stock par value $2.50 per share ("the Exchange Ratio"), subject to cash in lieu of fractional shares. The opening price of the BXS's common stock on the New York Stock Exchange on the effective date of the Merger was $29.16. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Cadence common stock. F2: Shares of Class A Common Stock held by WBH 2007 Revocable Trust and a grantor retained annuity trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of in connection with the Agreement and Plan of Merger by and between BancorpSouth Bank ("BXS") and Cadence Bancorporation ("Cadence"), dated April 12, 2021 and amended as of May of 27, 2021 (the "Merger Agreement"), pursuant to which Cadence was merged with and into BXS, effective October 29, 2021 (the "Merger"). Pursuant to the Merger, each issued and outstanding share of Cadence common stock par value $0.01 was converted into the right to receive .70 shares of the BXS's common stock par value $2.50 per share ("the Exchange Ratio"), subject to cash in lieu of fractional shares. The opening price of the BXS's common stock on the New York Stock Exchange on the effective date of the Merger was $29.16. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Cadence common stock.
F2: Shares of Class A Common Stock held by WBH 2007 Revocable Trust and a grantor retained annuity trust.
JPMORGAN CHASE & CO
Report date December 31, 2006 · Filed January 03, 2007
Section 16 reporting ended · disclosed 2007-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,173,569.2154 |
Reported balance
After 2006-12-31 transaction · row 1
1 source rowRow 1 · 2006-12-31 · Tax withholding · Disposed 30,277 · Balance 1,173,569.2154 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) | 18,466.23 |
Reported balance
Holding disclosure · report date 2006-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 18,466.23 |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 263,160 |
Reported balance
Holding disclosure · report date 2006-12-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 263,160 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 23,253 |
Reported balance
Holding disclosure · report date 2006-12-31 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 23,253 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 29, 2021 Filed Oct 29, 2021 15:49 UTC | Cadence Bancorporation CADE · Entity 134036 | Disposition to issuerClass A Common Stock, par value $0.01 per share | 571,961 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001702696-21-000066 · primary_doc.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · price: Disposed of in connection with the Agreement and Plan of Merger by and between BancorpSouth Bank ("BXS") and Cadence Bancorporation ("Cadence"), dated April 12, 2021 and amended as of May of 27, 2021 (the "Merger Agreement"), pursuant to which Cadence was merged with and into BXS, effective October 29, 2021 (the "Merger"). Pursuant to the Merger, each issued and outstanding share of Cadence common stock par value $0.01 was converted into the right to receive .70 shares of the BXS's common stock par value $2.50 per share ("the Exchange Ratio"), subject to cash in lieu of fractional shares. The opening price of the BXS's common stock on the New York Stock Exchange on the effective date of the Merger was $29.16. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Cadence common stock. F2 · ownership.nature: Shares of Class A Common Stock held by WBH 2007 Revocable Trust and a grantor retained annuity trust. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 15:49 UTC | Cadence Bancorporation CADE · Entity 134036 | Disposition to issuerClass A Common Stock, par value $0.01 per share | 120,102 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001702696-21-000066 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of in connection with the Agreement and Plan of Merger by and between BancorpSouth Bank ("BXS") and Cadence Bancorporation ("Cadence"), dated April 12, 2021 and amended as of May of 27, 2021 (the "Merger Agreement"), pursuant to which Cadence was merged with and into BXS, effective October 29, 2021 (the "Merger"). Pursuant to the Merger, each issued and outstanding share of Cadence common stock par value $0.01 was converted into the right to receive .70 shares of the BXS's common stock par value $2.50 per share ("the Exchange Ratio"), subject to cash in lieu of fractional shares. The opening price of the BXS's common stock on the New York Stock Exchange on the effective date of the Merger was $29.16. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Cadence common stock. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 15:30 UTC | Cadence Bancorporation CADE · Entity 134036 | GrantClass A Common Stock, par value $0.01 per share | 1,771 | $21.17 | $37,492.07 |
DisclosureSEC source: 0001702696-21-000055 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,102 F1 · shares: Director fees paid in stock. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 16:04 UTC | Cadence Bancorporation CADE · Entity 134036 | GrantClass A Common Stock, par value $0.01 per share | 1,719 | $21.81 | $37,491.39 |
DisclosureSEC source: 0001702696-21-000043 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,331 F1 · balance_after: Director fees paid in stock. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 15:14 UTC | Cadence Bancorporation CADE · Entity 134036 | GrantClass A Common Stock, par value $0.01 per share | 1,491 | $23.47 | $34,993.77 |
DisclosureSEC source: 0001702696-21-000015 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,612 F1 · shares: Director fee paid in stock. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 16:47 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 2,308.02 | $15.16 | $34,989.58 |
DisclosureSEC source: 0001702696-20-000067 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,121 Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 16:53 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 3,894 | $8.99 | $34,995.38 |
DisclosureSEC source: 0001702696-20-000055 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,813 F1 · balance_after: Total includes shares purchased through Dividend Reinvestment Plan in 2020. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 09:53 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 4,232 | $8.27 | $34,992.29 |
DisclosureSEC source: 0001702696-20-000041 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,601 Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 16:22 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 4,412 | $7.93 | $34,995.54 |
DisclosureSEC source: 0001702696-20-000016 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,368 Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 17:15 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 1,987.5184 | $17.61 | $35,000.00 |
DisclosureSEC source: 0001702696-19-000056 · primary_doc.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,555.7573 Read SEC document |
| December 13, 2019 Filed Dec 20, 2019 17:15 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 71.6689 | $17.02 | $1,220.07 |
DisclosureSEC source: 0001702696-19-000056 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,968.2389 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 18:13 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 1,948.7751 | $17.96 | $35,000.00 |
DisclosureSEC source: 0001702696-19-000041 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,896.57 Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 11:56 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 64,168 | $15.53 | $996,529.04 |
DisclosureSEC source: 0001702696-19-000035 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 571,961 F1 · shares: Shares of Class A Common Stock purchased in the WBH 2007 Revocable Trust. F2 · ownership.nature: Shares of Class A Common Stock held by the WBH 2007 Revocable Trust and a grantor retained annuity trust. Read SEC document |
| June 14, 2019 Filed Jun 19, 2019 13:27 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock par value $0.01 per share | 28.0706 | $19.84 | $556.94 |
DisclosureSEC source: 0001702696-19-000026 · primary_doc.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,899.3227 F1 · shares: Dividend Reinvestment purchase. Read SEC document |
| June 14, 2019 Filed Jun 19, 2019 13:27 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock Par Value $0.01 per share | 1,764.0507 | $19.84 | $35,000.00 |
DisclosureSEC source: 0001702696-19-000026 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,871.2521 Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 16:14 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 3,188.2014 | $20.00 | $63,750.00 |
DisclosureSEC source: 0001702696-19-000001 · primary_doc.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,107 Read SEC document |
| October 24, 2018 Filed Oct 26, 2018 16:40 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 23,000 | $21.72 | $499,447.30 |
DisclosureSEC source: 0000899243-18-027542 · doc4.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 23,000 F1 · price: The reported price in Column 4 is a weighted average price. These shares of Class A common stock, par value $0.01 per share (the "Class A Common Stock") of Cadence Bancorporation (the "Company") were sold in multiple transactions at prices ranging from $21.68 to $21.775 per share of Class A Common Stock, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission, upon written request, full information regarding the number of shares of Class A Common Stock sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares of Class A Common Stock held by the WBH 2007 Revocable Trust. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 19:03 UTC | Cadence Bancorporation CADE · Entity 134036 | OtherClass A Common Stock, par value $0.01 per share | 484,793 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-024350 · doc4.xml · nonDerivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 484,793 F2 · shares: Represents shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock") of Cadence Bancorporation received by a grantor retained annuity trust in a pro rata in-kind distribution of shares of Class A Common Stock held by Cadence Bancorp, LLC to its unitholders, without consideration. F2 · price: Represents shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock") of Cadence Bancorporation received by a grantor retained annuity trust in a pro rata in-kind distribution of shares of Class A Common Stock held by Cadence Bancorp, LLC to its unitholders, without consideration. F3 · ownership.nature: Held by a grantor retained annuity trust. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 19:03 UTC | Cadence Bancorporation CADE · Entity 134036 | OtherClass A Common Stock, par value $0.01 per share | 50,919 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-024350 · doc4.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,919 F1 · shares: Represents shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock") of Cadence Bancorporation received by the Reporting Person in a pro rata in-kind distribution of shares of Class A Common Stock held by Cadence Bancorp, LLC to its unitholders, without consideration. F1 · price: Represents shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock") of Cadence Bancorporation received by the Reporting Person in a pro rata in-kind distribution of shares of Class A Common Stock held by Cadence Bancorp, LLC to its unitholders, without consideration. Read SEC document |
| April 19, 2017 Filed Apr 19, 2017 18:11 UTC | Cadence Bancorporation CADE · Entity 134036 | PurchaseClass A Common Stock, par value $0.01 per share | 40,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-010575 · doc4.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · shares: Represents shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock") of Cadence Bancorporation purchased through a directed share program in connection with the initial public offering of the Class A Common Stock (the "IPO"), which closed on April 19, 2017. The shares of Class A Common Stock were purchased at the initial public offering price of $20.00 per share. The shares are subject to a lock up provision for a period of 180 days, as required under a lock-up agreement with the underwriters of the IPO. F1 · price: Represents shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock") of Cadence Bancorporation purchased through a directed share program in connection with the initial public offering of the Class A Common Stock (the "IPO"), which closed on April 19, 2017. The shares of Class A Common Stock were purchased at the initial public offering price of $20.00 per share. The shares are subject to a lock up provision for a period of 180 days, as required under a lock-up agreement with the underwriters of the IPO. Read SEC document |
| April 13, 2016 Filed Apr 13, 2016 19:03 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $34.44 | $0.00 |
DisclosureSEC source: 0001225208-16-031395 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009. Read SEC document |
| April 13, 2016 Filed Apr 13, 2016 19:03 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 5,000 | $34.44 | $172,200.00 |
DisclosureSEC source: 0001225208-16-031395 · doc4.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2016 Filed Apr 4, 2016 20:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 756.0008 | $52.91 | $40,000.00 |
DisclosureSEC source: 0001225208-16-030774 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,601.9821 Underlying: Common Stock · 756.0008 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2015 Filed Jan 4, 2016 18:59 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 686.2931 | $52.82 | $36,250.00 |
DisclosureSEC source: 0001225208-16-023077 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,166.2473 Underlying: Common Stock · 686.2931 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2015 Filed Oct 1, 2015 18:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 733.9542 | $49.39 | $36,250.00 |
DisclosureSEC source: 0001225208-15-018844 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,825.5632 Underlying: Common Stock · 733.9542 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2015 Filed Jul 1, 2015 20:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 636.7469 | $56.93 | $36,250.00 |
DisclosureSEC source: 0001225208-15-014677 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,519.728 Underlying: Common Stock · 636.7469 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013063 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,882.9811 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 13, 2015 Filed Apr 13, 2015 21:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $33.83 | $0.00 |
DisclosureSEC source: 0001225208-15-009975 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2015-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in equal installments on 4/29/2006, 4/29/2007 and 4/29/2008. Read SEC document |
| April 13, 2015 Filed Apr 13, 2015 21:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 5,000 | $33.83 | $169,150.00 |
DisclosureSEC source: 0001225208-15-009975 · doc4.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2015 Filed Apr 1, 2015 21:25 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 630.6541 | $57.48 | $36,250.00 |
DisclosureSEC source: 0001225208-15-009023 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,874.2974 Underlying: Common Stock · 630.6541 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2014 Filed Jan 2, 2015 18:54 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 638.3166 | $56.79 | $36,250.00 |
DisclosureSEC source: 0001225208-15-000054 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,755.9273 Underlying: Common Stock · 638.3166 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2014 Filed Oct 2, 2014 15:19 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 611.5047 | $59.28 | $36,250.00 |
DisclosureSEC source: 0001225208-14-020885 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,613.3207 Underlying: Common Stock · 611.5047 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2014 Filed Jul 1, 2014 20:41 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 626.6206 | $57.85 | $36,250.00 |
DisclosureSEC source: 0001225208-14-015973 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,503.5202 Underlying: Common Stock · 626.6206 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:01 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014281 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,876.8996 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 15:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $47.23 | $0.00 |
DisclosureSEC source: 0001225208-14-011273 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2014-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 15:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 5,000 | $47.23 | $236,150.00 |
DisclosureSEC source: 0001225208-14-011273 · doc4.xml · nonDerivative · entry 1 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2014 Filed Apr 2, 2014 15:43 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 638.5415 | $56.77 | $36,250.00 |
DisclosureSEC source: 0001225208-14-009486 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,788.9442 Underlying: Common Stock · 638.5415 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2013 Filed Jan 2, 2014 21:46 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 724.2757 | $50.05 | $36,250.00 |
DisclosureSEC source: 0001225208-14-000152 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,612.3277 Underlying: Common Stock · 724.2757 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2013 Filed Oct 2, 2013 13:50 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 761.3947 | $47.61 | $36,250.00 |
DisclosureSEC source: 0001225208-13-020961 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,352.9681 Underlying: Common Stock · 761.3947 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 28, 2013 Filed Jul 1, 2013 19:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 780.409 | $46.45 | $36,250.00 |
DisclosureSEC source: 0001225208-13-015096 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,062.9604 Underlying: Common Stock · 780.409 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 31, 2013 Filed Jun 3, 2013 19:07 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 3,211.9914 | $46.70 | $150,000.00 |
DisclosureSEC source: 0001225208-13-013658 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,282.5514 Underlying: Common Stock · 3,211.9914 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 28, 2013 Filed Apr 1, 2013 20:54 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 820.1357 | $44.20 | $36,250.00 |
DisclosureSEC source: 0001225208-13-008801 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,558.5377 Underlying: Common Stock · 820.1357 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 15:47 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 885.4421 | $40.94 | $36,250.00 |
DisclosureSEC source: 0001225208-13-000332 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,205.0341 Underlying: Common Stock · 885.4421 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 28, 2012 Filed Oct 1, 2012 16:09 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 803.7694 | $45.10 | $36,250.00 |
DisclosureSEC source: 0001225208-12-020280 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,856.1914 Underlying: Common Stock · 803.7694 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 29, 2012 Filed Jul 2, 2012 18:51 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 868.2635 | $41.75 | $36,250.00 |
DisclosureSEC source: 0001225208-12-015158 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,557.0673 Underlying: Common Stock · 868.2635 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 25, 2012 Filed May 29, 2012 19:22 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 3,994.6738 | $37.55 | $150,000.00 |
DisclosureSEC source: 0001225208-12-013301 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,688.8038 Underlying: Common Stock · 3,994.6738 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 15:58 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 944.0104 | $38.40 | $36,250.00 |
DisclosureSEC source: 0001225208-12-008832 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,214.0524 Underlying: Common Stock · 944.0104 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 30, 2011 Filed Jan 4, 2012 20:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 961.5385 | $37.70 | $36,250.00 |
DisclosureSEC source: 0001225208-12-000391 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,801.3605 Underlying: Common Stock · 961.5385 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2011 Filed Oct 4, 2011 17:34 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,108.5627 | $32.70 | $36,250.00 |
DisclosureSEC source: 0001225208-11-022661 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,344.1087 Underlying: Common Stock · 1,108.5627 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2011 Filed Jul 1, 2011 13:47 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,027.2032 | $35.29 | $36,250.00 |
DisclosureSEC source: 0001225208-11-016981 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,816.9394 Underlying: Common Stock · 1,027.2032 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.